ELAM-1 inhibitors (Affymax)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameELAM-1 inhibitors (Affymax)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsInflammationHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffymax Technologies NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffymax Technologies NV
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A